Skip to main content
Clinical Trials/IRCT138808111414N4
IRCT138808111414N4
Completed
Phase 1

Efficacy assessment of the Superporous Hydrogel (SPH) polymer-based oral insulin delivery systems on plasma glucose in patients with type 1 diabetes

Endocrinology and Metabolism Research Center0 sites15 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Dibetes mellitus.
Sponsor
Endocrinology and Metabolism Research Center
Enrollment
15
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Endocrinology and Metabolism Research Center

Eligibility Criteria

Inclusion Criteria

  • inclusion criteria: type1 diabetes, age of 17 \- 45 years and the BMI levels \=19 and \= 27 kg/m2\.
  • Exclusion criteria : any significant GI symptoms, previous hypersensitivity to polymer, clinically diagnosed diabetic gastroparesia, C\-peptide\> 0\.5 ng/dl, forcing patients to use drugs intervention with insulin during study (LHRH agonists, cimetidine, ranitidine, quinolones, estrogen, diuretics, glucocorticoids, ß blockers, somatostatins, pegvisomant, thiazolidinediones and herbal medicines), history of GI bleeding, history of uncontrolled thyroid disease, history of acute febrile illness, history of blood donate in the past 3 months, psychological disease, cardiac disease.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials